Oxygen deprivation in breast cancer: mechanisms, pathways, and implications
- PMID: 40486584
- PMCID: PMC12140683
- DOI: 10.1097/MS9.0000000000003334
Oxygen deprivation in breast cancer: mechanisms, pathways, and implications
Abstract
Hypoxia, a state of reduced oxygen availability, is a defining feature of the tumor microenvironment in breast cancer. It arises from the rapid proliferation of cancer cells, which outpaces the development of adequate vasculature. This oxygen deprivation triggers a cascade of molecular and cellular adaptations that enable tumor cells to survive and thrive under hostile conditions. Key among these is the stabilization of hypoxia-inducible factors, which regulate genes involved in angiogenesis, metabolic reprogramming, immune evasion, and cell survival. Hypoxia significantly influences breast cancer behavior, promoting tumor aggressiveness, therapeutic resistance, and metastatic potential. The hypoxic microenvironment fosters angiogenesis through vascular endothelial growth factor signaling, albeit leading to abnormal and inefficient vasculature. It also reprograms cancer cell metabolism towards glycolysis, supporting survival and growth in oxygen-deprived regions. Furthermore, hypoxia modulates immune responses, suppressing anti-tumor immunity while promoting the recruitment of immunosuppressive cells. These multifaceted effects underscore hypoxia's pivotal role in shaping the clinical trajectory of breast cancer.
Keywords: breast cancer; hypoxia; hypoxia-inducible factors; therapeutic resistance; tumor microenvironment.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. The author declares no conflict of interest.
Figures
Similar articles
-
Oxygen gradients in tumor tissues implications for breast cancer metastasis - a narrative review.Ann Med Surg (Lond). 2025 May 12;87(6):3372-3380. doi: 10.1097/MS9.0000000000003121. eCollection 2025 Jun. Ann Med Surg (Lond). 2025. PMID: 40486631 Free PMC article. Review.
-
Hypoxia-Induced Reactive Oxygen Species: Their Role in Cancer Resistance and Emerging Therapies to Overcome It.Antioxidants (Basel). 2025 Jan 15;14(1):94. doi: 10.3390/antiox14010094. Antioxidants (Basel). 2025. PMID: 39857427 Free PMC article. Review.
-
Regulation of CMGC kinases by hypoxia.BMB Rep. 2023 Nov;56(11):584-593. doi: 10.5483/BMBRep.2023-0165. BMB Rep. 2023. PMID: 37915135 Free PMC article. Review.
-
Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point?Front Oncol. 2023 Mar 28;13:1063051. doi: 10.3389/fonc.2023.1063051. eCollection 2023. Front Oncol. 2023. PMID: 37056346 Free PMC article. Review.
-
Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more.Biomed Pharmacother. 2021 Sep;141:111798. doi: 10.1016/j.biopha.2021.111798. Epub 2021 Jun 10. Biomed Pharmacother. 2021. PMID: 34120068 Review.
References
-
- Bray F, Ferlay J, Soerjomataram I, et al. . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424. - PubMed
-
- Harris AL. Hypoxia – a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38–47. - PubMed
-
- Warburg O. On the origin of cancer cells. Science 1956;123:309–14. - PubMed
Publication types
LinkOut - more resources
Full Text Sources